MARKET

HELP

HELP

Cybin Inc
NASDAQ
13.66
+1.29
+10.43%
After Hours: 13.99 +0.33 +2.42% 17:42 09/21 EDT
OPEN
12.65
PREV CLOSE
12.37
HIGH
14.05
LOW
12.65
VOLUME
2.86M
TURNOVER
--
52 WEEK HIGH
15.15
52 WEEK LOW
3.760
MARKET CAP
998.00M
P/E (TTM)
-4.5652
1D
5D
1M
3M
1Y
5Y
1D
Helus Pharma CEO to Spotlight Novel Serotonergic Pipeline at TD Cowen Neuropsychiatry Summit
TipRanks · 54m ago
Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit
Barchart · 6h ago
Helus Pharma Showcases New HLP003 Data in Major Depressive Disorder at Psych Congress 2026
TipRanks · 10h ago
Helus Pharma Presents Four Posters Evaluating HLP003 To Treat Major Depressive Disorder At Psych Congress 2026
Benzinga · 10h ago
Helus Pharma presents new analyses on HLP003 in MDD
TipRanks · 10h ago
Weekly Report: what happened at HELP last week (0914-0918)?
Weekly Report · 12h ago
Helus Pharma selloff Friday a buying opportunity, says Barclays
TipRanks · 13h ago
Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026
Barchart · 16h ago
More
About HELP
Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N, N-dimethyltryptamine (DMT) and dDMT programs create a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II.CYB005 is in Preclinical stage. It has an intellectual property portfolio in the psychedelic drug development sector with over 80 patents granted and over 230 patent applications pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands, and Ireland.

Webull offers Cybin Inc stock information, including NASDAQ: HELP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HELP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HELP stock methods without spending real money on the virtual paper trading platform.